Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leon Aarons

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|February 25, 2011
Structural identifiability analysis of pharmacokinetic models using DAISY: semi-mechanistic gastric emptying models for 13C-octanoic acidKayode Ogungbenro, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|June 11, 2011
Population Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experimentsKayode Ogungbenro, Leon Aarons
Journal of Biopharmaceutical Statistics|July 9, 2008
Analytical expressions for combining population pharmacokinetic parameters from different studiesAristides Dokoumetzidis, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|November 26, 2009
A method for robust model order reduction in pharmacokineticsAristides Dokoumetzidis, Leon Aarons
Journal of Biopharmaceutical Statistics|November 11, 2008
Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observationsKayode Ogungbenro, Leon Aarons
Journal of Biopharmaceutical Statistics|September 22, 2007
Bayesian optimal designs for pharmacokinetic models: sensitivity to uncertaintyAristides Dokoumetzidis, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|December 14, 2005
Propagation of population PK and PD information using a Bayesian approach: dealing with non-exchangeabilityAristides Dokoumetzidis, Leon Aarons
Pharmaceutical Research|July 24, 2014
A physiologically based pharmacokinetic model for clobazam and stiripentol in adults and childrenKayode Ogungbenro, Leon Aarons,
Journal of Pharmacokinetics and Pharmacodynamics|December 15, 2015
What do we mean by identifiability in mixed effects models?Marc Lavielle, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|March 22, 2014
Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexateKayode Ogungbenro, Leon Aarons,
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Journal of Pharmacokinetics and Pharmacodynamics|February 25, 2011
Structural identifiability analysis of pharmacokinetic models using DAISY: semi-mechanistic gastric emptying models for 13C-octanoic acidKayode Ogungbenro, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|June 11, 2011
Population Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experimentsKayode Ogungbenro, Leon Aarons
Journal of Biopharmaceutical Statistics|July 9, 2008
Analytical expressions for combining population pharmacokinetic parameters from different studiesAristides Dokoumetzidis, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|November 26, 2009
A method for robust model order reduction in pharmacokineticsAristides Dokoumetzidis, Leon Aarons
Journal of Biopharmaceutical Statistics|November 11, 2008
Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observationsKayode Ogungbenro, Leon Aarons
Journal of Biopharmaceutical Statistics|September 22, 2007
Bayesian optimal designs for pharmacokinetic models: sensitivity to uncertaintyAristides Dokoumetzidis, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|December 14, 2005
Propagation of population PK and PD information using a Bayesian approach: dealing with non-exchangeabilityAristides Dokoumetzidis, Leon Aarons
Pharmaceutical Research|July 24, 2014
A physiologically based pharmacokinetic model for clobazam and stiripentol in adults and childrenKayode Ogungbenro, Leon Aarons,
Journal of Pharmacokinetics and Pharmacodynamics|December 15, 2015
What do we mean by identifiability in mixed effects models?Marc Lavielle, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|March 22, 2014
Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexateKayode Ogungbenro, Leon Aarons,
Pageof 13